OTC market in Central and Eastern Europe: what should we expect in 2011-2013? - September 2011

In 2009 the OTC product market in the region was worth around €9.2bn, rising only 1% y-o-y, according to our report “OTC market in Central and Eastern Europe 2011. Development forecasts for 2011-2013”. What are the key future trends which may influence market growth in the coming years?

Russia, Ukraine, and Slovakia are the only CEE (Central and Eastern European) countries in which non-pharmacy sales of pharmaceuticals are not allowed. A proposal by the Russian Ministry of Industry and Trade to allow such sales was rejected by the Ministry of Health and Social Development and any possible changes in Ukraine are more likely to focus on reducing the number of people practising self-medication. Now, it seems, Slovakia is seriously considering changes in legislation in this area.

To open the FULL free article/document, please sign up.

*required


*Email:
		To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs. Why do you sign up?		Please specify:
		Privacy Policy

Free e-letters

PMR Publications provides market intelligence for business professionals interested in Central and Eastern European countries as well as other emerging markets. Publications by PMR analyse the business climate in the region. The offer includes both free and paid subscription newsletters, online news & analysis services and in-depth reports on Central and Eastern Europe. PMR Publications is a division of PMR, a British-American company providing market research (through PMR Research), consultancy (through PMR Consulting) and business publications (through PMR Publications).